Skip to main content

Evoke Wealth, LLC

SEC CIK
0001793432
Latest filing
Aug 10, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Evoke Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of ABBV by Evoke Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−24,240−100.0%Sold outHolders
Q1 202624,240$5.27M0.1%−5,717−19.1%ReducedHolders
Q4 202529,957$6.84M0.1%−251−0.8%ReducedHolders
Q3 202530,208$6.99M0.1%+1,576+5.5%AddedHolders
Q2 202528,632$5.31M0.1%+4,758+19.9%AddedHolders
Q1 202523,874$5.00M0.1%+1,392+6.2%AddedHolders
Q4 202422,482$4.00M0.1%+2,556+12.8%AddedHolders
Q3 202419,926$3.94M0.1%+19,926NewHolders
Q2 20240$00.0%−19,748−100.0%Sold outHolders
Q1 202419,748$3.60M0.1%+19,748NewHolders
Q4 20230$00.0%−21,105−100.0%Sold outHolders
Q3 202321,105$3.15M0.1%+405+2.0%AddedHolders
Q2 202320,700$2.79M0.1%+222+1.1%AddedHolders
Q1 202320,478$3.26M0.1%+337+1.7%AddedHolders
Q4 202220,141$3.25M0.1%+39+0.2%AddedHolders
Q3 202220,102$2.70M0.1%+100.0%AddedHolders
Q2 202220,092$3.08M0.1%−65−0.3%ReducedHolders
Q1 202220,157$3.27M0.1%−2,804−12.2%ReducedHolders
Q4 202122,961$3.11M0.1%−1,290−5.3%ReducedHolders
Q3 202124,251$2.62M0.1%−133−0.5%ReducedHolders
Q2 202124,384$2.75M0.1%+5,638+30.1%AddedHolders
Q1 202118,746$2.03M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.